Emerging Trends to Drive Autoimmune Treatment Market Growth at 14.1% CAGR Through 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Autoimmune Treatment Market Size Growth Forecast: What to Expect by 2025?
The market size for autoimmune treatments has witnessed a significant expansion in the previous years. This growth is projected to continue, increasing from $7.72 billion in 2024 to $8.66 billion in 2025, with a compound annual growth rate (CAGR) of 12.1%. The historical growth can be ascribed to factors like increasing incidence of autoimmune diseases, progressive developments in immunology, insights from genetic research, heightened patient consciousness and advocacy, and supportive regulatory frameworks.

How Will the Autoimmune Treatment Market Size Evolve and Grow by 2029?
Expectations are high for rapid expansion in the size of the autoimmune treatment market within the coming years. Predictions forecast it escalating to $14.66 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 14.1%. Factors contributing to this projected growth during the estimation period include the emergence of precision medicine strategies, the development of small molecule therapies, innovations in gene therapy, an increased investment in biopharmaceuticals, and growth in the biosimilar market. Significant trends within the projected period encompass advancements in biologics and targeted therapies, the growth of immunomodulatory therapies, a concentrated focus on rare autoimmune conditions, the incorporation of telemedicine and remote patient monitoring, regulatory activities and drug approval processes, as well as the amalgamation of digital health tools.

View the full report here:
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

What Drivers Are Propelling the Growth of Autoimmune Treatment Market Forward?
The growth of the autoimmune treatment market is anticipated to be driven by increased investments in the research and development of drugs for autoimmune disorders. Companies engage in research and development to be innovative and introduce new products and services. Through research and development of drugs for autoimmune diseases, more specialized, orally-administered, low-molecular-weight, and chemically defined immune-suppressive drugs are developed with acceptable tolerability, particularly relevant for long-term treatment of autoimmune diseases. For example, Eli Lilly and Company, an American pharmaceutical company, raised its R&D investment from $7 billion in 2021 to $7.19 billion in 2022. This resulted in an increase in the company's R&D expenditure as a share of its revenue, going from 24.8% to 25.19%. Consequently, the continual rise in research and development investments fuels the growth of the autoimmune treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

Which Emerging Trends Are Transforming the Autoimmune Treatment Market in 2025?
Advancements in technology are becoming a prominent trend in the autoimmune treatment market. Major market players are leveraging advanced technologies to maintain their market position. For example, UCB, a pharmaceutical firm based in Belgium, in June 2023, attained approval from the U.S. Food and Drug Administration (FDA) for their product RYSTIGGO (rozanolixizumab-noli) for treating generalized myasthenia gravis (gMG) in adults diagnosed with anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies. The approval process was sped up under Priority Review. It's worth noting that RYSTIGGO is the only FDA-approved treatment for both AchR and MuSK antibody-positive gMG, the two most common subtypes of this condition. This advancement can potentially enhance medical provider efficiency, boost treatment effectiveness, and improve the quality of patient care.

What Are the Key Segments in the Autoimmune Treatment Market?
The autoimmune treatment market covered in this report is segmented -

1) By Product: Consumables And Assay Kits, Instruments, Services
2) By Service Type: Consultation And Diagnosis, Therapy And monitoring, Drug development
3) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren's Syndrome, Thyroiditis, Scleroderma, Other Diseases
4) By Drug Class: Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class

Subsegments:
1) By Consumables And Assay Kits: ELISA Kits, Reagents And Antibodies, Sample Collection Kits
2) By Instruments: Diagnostic Equipment, Imaging Systems
3) By Services: Testing And Diagnostics Services, Consultation And Support Services, Data Analysis And Interpretation Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp

Who Are the Key Players Shaping the Autoimmune Treatment Market's Competitive Landscape?
Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.

What Geographic Markets Are Powering Growth in the Autoimmune Treatment Market?
North America was the largest region in the autoimmune treatment market in 2024. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7863

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.